
Insulet (NASDAQ:PODD) specializes in developing, manufacturing, and marketing innovative medical devices for people with insulin-dependent diabetes. Primarily known for its flagship product, the Omnipod Insulin Management System, Insulet aims to simplify diabetes management through its wearable, tubeless insulin pump technology. The company's projects revolve around enhancing the user experience, expanding global accessibility, and advancing diabetes technology to improve the lives of its users. With a commitment to innovation, Insulet is focused on continuing to grow its product portfolio, striving for advancements that can lead to better health outcomes and increased convenience for people living with diabetes worldwide.